Citation

80 FR 59797

Canonical document for this Federal Register citation.

Prospective Grant of a Start-up Exclusive Commercial License Agreement: Development of MHC Class II Restricted T Cell Epitopes From the Cancer Antigen, NY ESO-1, for the Treatment of Human Cancers Friday, October 2, 2015 80 FR 59797